Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study

Figure 2

Adjusted changes in FMD (ΔFMD) in the sitagliptin and voglibose groups. Values are the least square means (95% CI). The least square means (95% CIs) were derived from ANCOVA adjusted for the baseline FMD, age, sex, current smoking, diabetes duration and BMI. ΔFMD was significantly improved after 12 weeks of treatment in both groups, and there was no significant difference in ΔFMD between the two groups.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840